Counterfeit and falsified pharmaceuticals are a global public health threat in the pharmaceutical industry. These medications may not only be ineffective, but also harmful— producing negative side effects or even death.
The growing complexity and dynamism of global marketplaces provide enormous opportunities for counterfeiting, grey marketing, and tampering with branded and high-valued goods. This breakthrough has a broad impact on all
Human errors, data security, pharmaceutical supply chain transparency, a lack of interoperability between databases, and the dissemination of healthcare-related information are all current difficulties in the healthcare business. This existing
Counterfeiters can create nearly similar knockoff products to the originals thanks to technological advancements. Not only that, but they are capable of producing and disseminating fakes in a timely manner.
Near-Field Communication (NFC) is a critical driver for pharmaceutical businesses, which financial impact is increasing at a 6.9% yearly pace since 2014. However, there are significant obstacles, such as the
The proliferation of counterfeit drug trade has been fueled by the growth of international free trade and a lack of drug regulation. Technological protection is considered to be the most
